Ditchcarbon
  • Customers
  1. Organizations
  2. Quantoom Biosciences Sa
Public Profile
Pharmaceutical Preparation Manufacturing
BE
updated 5 months ago

Quantoom Biosciences Sa

Company website

Quantoom Biosciences SA, headquartered in Belgium, is a pioneering company in the biotechnology sector, specialising in advanced quantum technologies for life sciences. Founded in recent years, Quantoom has quickly established itself as a leader in the development of innovative solutions that enhance drug discovery and diagnostics. The company focuses on harnessing quantum computing and artificial intelligence to revolutionise the way biological data is processed and analysed. Their unique approach allows for unprecedented accuracy and efficiency in research, setting them apart in a competitive market. With a commitment to pushing the boundaries of science, Quantoom Biosciences has achieved significant milestones, positioning itself as a key player in the biotechnology landscape. Their cutting-edge products and services are designed to meet the evolving needs of researchers and healthcare professionals worldwide.

DitchCarbon Score

How does Quantoom Biosciences Sa's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Quantoom Biosciences Sa's score of 26 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

33%

Let us know if this data was useful to you

Quantoom Biosciences Sa's reported carbon emissions

Quantoom Biosciences Sa, headquartered in Belgium, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Quantoom Biosciences Sa may still be in the early stages of establishing its carbon footprint and climate commitments. As the company operates within the biosciences sector, it is essential for them to consider industry standards for sustainability and emissions reduction. Many organisations in this field are increasingly adopting Science-Based Targets Initiative (SBTi) guidelines to align their operations with global climate goals. However, without specific commitments or targets, it remains unclear how Quantoom Biosciences Sa plans to address its environmental impact. In summary, while Quantoom Biosciences Sa has not yet disclosed any emissions data or climate initiatives, the company is encouraged to develop a robust strategy to measure and reduce its carbon footprint in line with industry best practices.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Quantoom Biosciences Sa's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Quantoom Biosciences Sa is in BE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Quantoom Biosciences Sa is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Aldevron, LLC

US
•
Research and development services (73)
Updated 13 days ago

Blue Heron Biotechnology, Inc.

US
•
Research and development services (73)
Updated 13 days ago

Sigma-Aldrich Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

OriGene Technologies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Promega

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy